Physician profile
Brian D Kim
NPI 1386622421
$46,495.56
in general payments reported to CMS, 2019-2025
6 companies · $4,933 in 2025
The $4,933 reported for 2025 was more than what 88% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2021: $11K · 2022: $25K · 2023: $2,224 · 2024: $3,375 · 2025: $4,933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,375 · Education: $2,500 · Consulting Fee: $2,020 · Travel and Lodging: $1,823 · Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,375.00 |
| Education | $2,500.00 |
| Consulting Fee | $2,020.00 |
| Travel and Lodging | $1,822.74 |
| Food and Beverage | $813.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $35,447.15 | 2021-2023 | Matrixrib |
| Acumed LLC | $5,512.50 | 2022-2024 | Ribloc |
| Intuitive Surgical, INC. | $3,571.01 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $1,333.51 | 2025 | Advantagerib, Ribfix Titan |
| Depuy Synthes Sales INC. | $477.86 | 2021-2025 | Matrixrib |
| Kls-Martin L.P. | $153.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.